Arrowhead Research | Zysk Na Akcję



Fiscal Kalendarz Obecny Prognoza Poprzedni Data
FY2025Q2 Mar/2025 -0.107 -1.02 May/08 2025
FY2025Q1 Dec/2024 -1.39 -0.39 -1.24 Feb/10 2025
FY2024Q4 Sep/2024 -1.36 -0.97 -1.92 Nov/26 2024
FY2024Q3 Jun/2024 -1.38 -0.53 -0.96 Aug/08 2024
FY2024Q2 Mar/2024 -1.02 -0.47 0.45 May/09 2024
FY2024Q1 Dec/2023 -1.24 -0.80 -0.39 Feb/06 2024
FY2023Q4 Sep/2023 -1.92 -0.61 -0.81 Nov/29 2023
FY2023Q3 Jun/2023 -0.96 -0.73 -0.68 Aug/07 2023
FY2023Q2 Mar/2023 0.45 -0.68 0.41 May/02 2023
FY2023Q1 Dec/2022 -0.39 0.16 -0.6 Feb/06 2023
FY2022Q4 Sep/2022 -0.81 -0.29 -0.61 Nov/28 2022
FY2022Q3 Jun/2022 -0.68 -0.65 -0.29 Aug/04 2022

Eps Zmiana Data
Agios Pharmaceuticals USD -1.44 0.98 2024-12
Alnylam Pharmaceuticals USD -0.65 0.22 2024-12
Arrowhead Research USD -1.39 0.02 2024-12
Incyte USD 1.43 0.36 2024-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Ligand Pharmaceuticals USD 1.27 0.57 2024-12
Merck USD 1.72 0.15 2024-12
Moderna USD -2.91 2.94 2024-12
Novartis USD 1.98 0.4 2024-12
Sarepta Therapeutics USD 1.5 1.16 2024-12
TG Therapeutics USD 0.15 0.13 2024-12
Ultragenyx Pharmaceutical USD -1.39 0.01 2024-12
Vertex Pharmaceuticals USD 3.98 0.4 2024-12
Xencor USD -0.62 0.09 2024-12



Arrowhead Research Zysk Na Akcję - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.